Renalytix Plc
RNLX · NASDAQ
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,456 | -$46,221 | -$49,628 | -$35,788 |
| Dep. & Amort. | $364 | $2,492 | $2,613 | $2,096 |
| Deferred Tax | $0 | $3,366 | $0 | $3,760 |
| Stock-Based Comp. | $1,710 | $2,932 | $4,621 | $2,180 |
| Change in WC | -$3,529 | $6,184 | $16 | $3,615 |
| Other Non-Cash | $4,800 | -$55 | -$5,756 | -$495 |
| Operating Cash Flow | -$30,111 | -$32,674 | -$45,745 | -$24,632 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$694 | -$1,630 |
| Net Acquisitions | $0 | $0 | $0 | $472 |
| Inv. Purchases | $0 | $0 | $0 | -$1,337 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $1,000 |
| Other Inv. Act. | $0 | $0 | -$105 | $754 |
| Investing Cash Flow | -$4 | $0 | -$694 | -$741 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,660 | -$3,180 | $18,020 | $0 |
| Stock Issued | $13,626 | $20,557 | $9,210 | $77,239 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,716 | -$991 | -$1,600 | $1 |
| Financing Cash Flow | $10,250 | $15,118 | $25,515 | $77,239 |
| Forex Effect | -$137 | $905 | -$2,902 | $3,745 |
| Net Chg. in Cash | -$20,002 | -$16,651 | -$23,826 | $51,866 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24,682 | $41,333 | $65,159 | $13,293 |
| End Cash | $4,680 | $24,682 | $41,333 | $65,159 |
| Free Cash Flow | -$30,115 | -$32,674 | -$46,439 | -$26,262 |